EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Efficacy of Der f 2/Zen 1‐LAMP1 Plasmid‐Based Vaccine Immunotherapy in Dogs With Atopic Dermatitis: A Proof‐of‐Concept Study

Petra Bizikova iD, Chigusa Matsumoto, Shoji Ogino, Toshihiro Tsukui, Kim Love, Marcy Murphy, Ina Herrmann iD

Veterinary Dermatology · 2025

DOI: 10.1111/vde.70037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Dermatology, 2025. Verfasst von Petra Bizikova und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Dog Diseases, Antigens, Dermatophagoides, Vaccines, DNA. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nippon Zenyaku Kogyo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

DNA‐based vaccination rapidly induces strong cellular and humoral immune responses, which may be enhanced by inclusion of lysosomal‐associated membrane protein‐1 (LAMP).

Objectives

This proof‐of‐concept study evaluated the efficacy and safety of a Der f 2/Zen 1‐LAMP‐based DNA vaccine immunotherapy in client‐owned dogs with nonseasonal AD sensitised to Dermatophagoides farinae (Df) . Animals Fifteen dogs positive for Df only and 20 dogs with reactivity to additional environmental allergens received either a low (0.5 mg/0.1 mL) or high (2 mg/0.4 mL) dose of the vaccine intradermally. Materials and Methods Four doses of vaccine were administered every 2 weeks. Pruritus, Canine Atopic Dermatitis Extent and Severity Index (CADESI)‐04, average daily medication scores (AvdMS) and adverse events (AE) were recorded over 24 weeks. Owner perception of treatment efficacy (OGATE) was assessed at the end.

Results

Pruritus and CADESI‐04 improved regardless of the sensitisation profile and the vaccine dose. After 24 weeks, despite a statistically insignificant reduction of AvdMS, 71%, 46% and 86% of dogs reached PVAS < 3.6, PVAS < 2 and CADESI‐04 < 10, respectively. There was no statistically significant effect of AvdMS on PVAS or CADESI‐04, meaning that the concurrently administered topical and/or systemic treatment(s) were unlikely to have been responsible for the observed PVAS and CADESI‐04 reduction. Twenty‐one owners (60%) rated the vaccine efficacy as good‐to‐excellent. No severe AEs were reported. Conclusions and Clinical Relevance These results of this proof‐of‐concept study support not only the safety of DNA vaccine immunotherapy in dogs with AD, but also its potential clinical benefits. A double‐blinded, ≥ 12 month long, controlled study with more subjects should follow to further confirm the true efficacy of this vaccine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicDog DiseasesAntigens, DermatophagoidesVaccines, DNAImmunotherapyArthropod ProteinsAnimalsDogsMaleFemaleProof of Concept StudyPlasmids

Stichwörter der Autor:innen

Dermatophagoidesatopic dermatitishouse dust miteimmunotherapyvaccine

Substanzen

Antigens, DermatophagoidesVaccines, DNADermatophagoides farinae antigen f 2Arthropod Proteins

Autor:innen und Institutionen

  • College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.
  • Zenoaq, Koriyama, Fukushima, Japan.
  • K. R. Love Quantitative Consulting and Collaboration, Athens, Georgia, USA.

ORCID-Profile: Petra Bizikova, Ina Herrmann

Förderung

  • Nippon Zenyaku Kogyo

Zitieren

APA

Bizikova, P., Matsumoto, C., Ogino, S., Tsukui, T., Love, K., Murphy, M., & Herrmann, I. (2025). Efficacy of Der f 2/Zen 1‐LAMP1 Plasmid‐Based Vaccine Immunotherapy in Dogs With Atopic Dermatitis: A Proof‐of‐Concept Study. Veterinary Dermatology. https://doi.org/10.1111/vde.70037

Vancouver

Bizikova P, Matsumoto C, Ogino S, Tsukui T, Love K, Murphy M, et al. Efficacy of Der f 2/Zen 1‐LAMP1 Plasmid‐Based Vaccine Immunotherapy in Dogs With Atopic Dermatitis: A Proof‐of‐Concept Study. Veterinary Dermatology. 2025. doi:10.1111/vde.70037

BibTeX
@article{Bizikova2025,
  author = {Bizikova, Petra and Matsumoto, Chigusa and Ogino, Shoji and Tsukui, Toshihiro and Love, Kim and Murphy, Marcy and Herrmann, Ina},
  title = {Efficacy of Der f 2/Zen 1‐LAMP1 Plasmid‐Based Vaccine Immunotherapy in Dogs With Atopic Dermatitis: A Proof‐of‐Concept Study},
  journal = {Veterinary Dermatology},
  year = {2025},
  doi = {10.1111/vde.70037}
}
Kostenlos starten →